UPDATE: Needham On Lucid Buy Initiation: Firm Sees EsoGuard & Sample Collection System EsoCheck Presenting An 'Unmet Need With A Very Large Total Available Market' Of $25B In The U.S. Alone; Notes Long-Term Plans To Expand Into Treatment Using EsoCure